Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR). According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2022 and is forecast to a readjusted size of USD 3620.3 million by 2029 with a CAGR of 6.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%. The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share. This report is a detailed and comprehensive analysis for global Influenza Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Influenza Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029 Global Influenza Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Influenza Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Influenza Diagnostics market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Influenza Diagnostics To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Influenza Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott (Include Alere), Roche, SIEMENS and Analytik Jena, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Influenza Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type RIDT RT-PCR Cell Culture Others Market segment by Application Hospitals POCT Others Market segment by players, this report covers BD Abbott (Include Alere) Roche SIEMENS Analytik Jena Quidel Thermo Fisher Meridian Bioscience BioMerieux Sekisui Diagnostics Response Biomedical SA Scientific Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Influenza Diagnostics product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Influenza Diagnostics, with revenue, gross margin and global market share of Influenza Diagnostics from 2018 to 2023. Chapter 3, the Influenza Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Influenza Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Diagnostics. Chapter 13, to describe Influenza Diagnostics research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Influenza Diagnostics 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Influenza Diagnostics by Type 1.3.1 Overview: Global Influenza Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Influenza Diagnostics Consumption Value Market Share by Type in 2022 1.3.3 RIDT
